DE69805665T2 - 3,7-Dithiaprostansäure Derivate - Google Patents
3,7-Dithiaprostansäure DerivateInfo
- Publication number
- DE69805665T2 DE69805665T2 DE69805665T DE69805665T DE69805665T2 DE 69805665 T2 DE69805665 T2 DE 69805665T2 DE 69805665 T DE69805665 T DE 69805665T DE 69805665 T DE69805665 T DE 69805665T DE 69805665 T2 DE69805665 T2 DE 69805665T2
- Authority
- DE
- Germany
- Prior art keywords
- alkenyl
- alkyl
- alkynyl
- cycloalkyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- KNCQNMMWWSQZMW-IRXDYDNUSA-N 2-[3-[(1s,2s)-2-octylcyclopentyl]sulfanylpropylsulfanyl]acetic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1SCCCSCC(O)=O KNCQNMMWWSQZMW-IRXDYDNUSA-N 0.000 title abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000000304 alkynyl group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010067125 Liver injury Diseases 0.000 abstract 1
- 102000008866 Prostaglandin E receptors Human genes 0.000 abstract 1
- 108010088540 Prostaglandin E receptors Proteins 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000027455 binding Effects 0.000 abstract 1
- 231100000234 hepatic damage Toxicity 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000008818 liver damage Effects 0.000 abstract 1
- 201000008383 nephritis Diseases 0.000 abstract 1
- 230000016273 neuron death Effects 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000011164 ossification Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Microscoopes, Condenser (AREA)
- Steroid Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2719897 | 1997-01-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69805665D1 DE69805665D1 (de) | 2002-07-11 |
| DE69805665T2 true DE69805665T2 (de) | 2002-11-21 |
Family
ID=12214403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69805665T Expired - Fee Related DE69805665T2 (de) | 1997-01-27 | 1998-01-26 | 3,7-Dithiaprostansäure Derivate |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5892099A (de) |
| EP (1) | EP0855389B1 (de) |
| JP (1) | JPH10265454A (de) |
| AT (1) | ATE218543T1 (de) |
| DE (1) | DE69805665T2 (de) |
| DK (1) | DK0855389T3 (de) |
| ES (1) | ES2182220T3 (de) |
| PT (1) | PT855389E (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6043275A (en) * | 1998-04-16 | 2000-03-28 | Ono Pharmaceutical Co., Ltd. | 3,7-dithiaprostanoic acid derivative |
| US6437146B1 (en) | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
| CA2346031A1 (en) * | 1998-10-15 | 2000-04-20 | Merck & Co., Inc. | Methods for stimulating bone formation |
| US6414006B1 (en) | 1998-10-15 | 2002-07-02 | Merck Frosst Canada & Co. | Methods for inhibiting bone resorption |
| JP4834224B2 (ja) | 1999-03-05 | 2011-12-14 | デューク ユニバーシティ | Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体 |
| CN1304319A (zh) * | 1999-03-16 | 2001-07-18 | 东丽株式会社 | 子宫颈管成熟剂及子宫颈管成熟方法 |
| US6894175B1 (en) * | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| TWI247606B (en) | 1999-11-24 | 2006-01-21 | Ono Pharmaceutical Co | Treating agent for osteopenic diseases |
| JP4618548B2 (ja) * | 1999-11-24 | 2011-01-26 | 小野薬品工業株式会社 | 骨量低下疾患治療剤 |
| IL141120A0 (en) * | 2000-01-31 | 2002-02-10 | Pfizer Prod Inc | Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure |
| US20020172693A1 (en) * | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US20020013294A1 (en) * | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US20020146439A1 (en) * | 2000-03-31 | 2002-10-10 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
| WO2002024647A1 (fr) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine |
| GB0103269D0 (en) * | 2001-02-09 | 2001-03-28 | Glaxo Group Ltd | Napthalene derivatives |
| US6410591B1 (en) | 2001-05-08 | 2002-06-25 | Allergan Sales, Inc. | 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| US20050222094A1 (en) * | 2001-06-14 | 2005-10-06 | Burk Robert M | Treatment of inflammatory bowel disease |
| US20030027853A1 (en) | 2001-06-14 | 2003-02-06 | Allergan Sales, Inc. | 3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| US7872045B2 (en) | 2001-06-14 | 2011-01-18 | Allergan, Inc. | Combination therapy for glaucoma treatment |
| EP1490055A1 (de) * | 2002-03-18 | 2004-12-29 | Pfizer Products Inc. | Verwendung von selektiven ep4 rezeptor-agonisten zur behandlung von leberinsuffizienz, verlust der durchgängigkeit des ductus arteriosus, glaukom oder okularer hypertonie |
| JP2005521726A (ja) * | 2002-03-27 | 2005-07-21 | チャーターハウス セラピューティックス リミテッド | 医薬化合物における改良 |
| JP4766875B2 (ja) | 2002-06-06 | 2011-09-07 | メルク フロスト カナダ リミテツド | Ｅｐ４受容体作動薬、組成物及びその方法 |
| US7053085B2 (en) | 2003-03-26 | 2006-05-30 | Merck & Co. Inc. | EP4 receptor agonist, compositions and methods thereof |
| WO2004073589A2 (en) * | 2003-02-24 | 2004-09-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep4 (prostaglandin e2 ep4) |
| EP1742662A2 (de) * | 2004-05-03 | 2007-01-17 | Astellas Pharma Inc. | Kombination aus prostaglandin-e2-rezeptor-antagonisten und renin-angiotensin-system-hemmer zur behandlung von nierenerkrankungen |
| US20080234337A1 (en) * | 2004-08-10 | 2008-09-25 | Ono Pharmaceutical Co., Ltd. | Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist |
| EP1812017A2 (de) | 2004-10-21 | 2007-08-01 | Duke University | Ophthalmologische arzneimittel |
| UY30121A1 (es) | 2006-02-03 | 2007-08-31 | Glaxo Group Ltd | Nuevos compuestos |
| US9394520B2 (en) | 2006-12-08 | 2016-07-19 | University Of Rochester | Expansion of hematopoietic stem cells |
| JP5069752B2 (ja) | 2006-12-15 | 2012-11-07 | グラクソ グループ リミテッド | Ｅｐ４受容体アゴニストとしてのベンズアミド誘導体 |
| GB0721611D0 (en) | 2007-11-02 | 2007-12-12 | Glaxo Group Ltd | Novel compounds |
| US8623918B2 (en) * | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| CA2738045C (en) | 2010-05-28 | 2019-02-19 | Simon Fraser University | Conjugate compounds, methods of making same, and uses thereof |
| US9650414B1 (en) | 2014-05-30 | 2017-05-16 | Simon Fraser University | Dual-action EP4 agonist—bisphosphonate conjugates and uses thereof |
| CA2988523A1 (en) | 2015-06-12 | 2016-12-15 | Simon Fraser University | Amide-linked ep4 agonist-bisphosphonate compounds and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57108065A (en) * | 1980-12-26 | 1982-07-05 | Teijin Ltd | 7-thiaprostaglandin e1 derivative, its preparation, and blood platelet coagulation inhibiting agent containing said derivative as active component |
| EP0051284B1 (de) * | 1980-10-31 | 1985-01-09 | Teijin Limited | Thiaprostaglandin E1-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
| JPS58110562A (ja) * | 1981-12-25 | 1983-07-01 | Teijin Ltd | 新規な７−チアプロスタグランジンｅ↓１誘導体類、それらの製造方法及びそれらを活性成分とする薬剤 |
| JPS58148857A (ja) * | 1982-02-26 | 1983-09-05 | Teijin Ltd | 新規な１３，１４−ジヒドロ−７−チアプロスタグランジンｅ↓１類およびその製造方法 |
-
1998
- 1998-01-12 JP JP10016362A patent/JPH10265454A/ja not_active Withdrawn
- 1998-01-26 AT AT98300513T patent/ATE218543T1/de not_active IP Right Cessation
- 1998-01-26 PT PT98300513T patent/PT855389E/pt unknown
- 1998-01-26 DK DK98300513T patent/DK0855389T3/da active
- 1998-01-26 EP EP98300513A patent/EP0855389B1/de not_active Expired - Lifetime
- 1998-01-26 DE DE69805665T patent/DE69805665T2/de not_active Expired - Fee Related
- 1998-01-26 ES ES98300513T patent/ES2182220T3/es not_active Expired - Lifetime
- 1998-01-27 US US09/013,885 patent/US5892099A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69805665D1 (de) | 2002-07-11 |
| EP0855389A2 (de) | 1998-07-29 |
| DK0855389T3 (da) | 2002-10-14 |
| JPH10265454A (ja) | 1998-10-06 |
| ATE218543T1 (de) | 2002-06-15 |
| US5892099A (en) | 1999-04-06 |
| PT855389E (pt) | 2002-10-31 |
| EP0855389B1 (de) | 2002-06-05 |
| ES2182220T3 (es) | 2003-03-01 |
| EP0855389A3 (de) | 1999-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69805665D1 (de) | 3,7-Dithiaprostansäure Derivate | |
| DE69412534T2 (de) | Piperazin-Derivate und ihre Verwendung als Calmodulin-Inhibitoren | |
| ATE305465T1 (de) | Pyrimidinylbenzimidazol- und triazinylbenzimidazol-derivate und agrikulte/hortikulte fungizide | |
| ES2191260T3 (es) | Derivados de la imidazolidin-4-ona utiles como agentes anticancerosos. | |
| AU3464097A (en) | Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same | |
| PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
| DE69725585D1 (de) | Phenylalkylcarbonsäure-derivate | |
| ATE537158T1 (de) | M-stage-kinesin-inhibitor | |
| DE60220296D1 (de) | IMIDAZO(1,2-a)PYRIMIDINE UND DIESE ENTHALTENDE FUNGIZIDZUSAMMENSETZUNGEN | |
| DE60002558D1 (de) | Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B | |
| DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| NO305956B1 (no) | Benzenderivat nyttig for ischemiske sykdommer | |
| DE69934587D1 (de) | Thiazolidin-derivate | |
| BR9813241A (pt) | Derivados de guanidina substituìdos | |
| AU2001228862A1 (en) | Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives | |
| IL84300A (en) | Herbicidal compositions containing 1-(2-(hetero)-arylsulphonylcarbanoyl)-2-pyrazoline derivatives,certain such novel compounds and their preparation | |
| ATE139764T1 (de) | Substituierte benzoate-derivate | |
| HK1042654A1 (en) | Neuropathy improvers containing nitrogenous compounds as the active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |